SCHEMBL5845870

SCHEMBL5845870

Nc1ccc(C(F)(C(F)(F)F)C(F)(F)Br)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.42
TSHR P16473 6/20 0.42
ALDH1A1 P00352 4/20 0.41
MAPK1 P28482 1/20 0.41
ALOX15 P16050 2/20 0.35
ESR2 Q92731 1/20 0.35
THRB P10828 1/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.35
RECQL P46063 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5958724 0.90 TSHR (0.46) CYP3A4TSHRALDH1A1MAPK1ALOX15
SCHEMBL297990 0.85 CYP3A4 (0.42) CYP3A4TSHRALDH1A1MAPK1ALOX15
SCHEMBL3894118 0.81 CYP3A4 (0.45) CYP3A4TSHRALDH1A1MAPK1ALOX15
SCHEMBL5847207 0.79 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10CA12CA1
SCHEMBL5846633 0.79 CA12 (0.37) ALDH1A1HPGDHSD17B10CA12CA1
SCHEMBL13516413 0.79 ALDH1A1 (0.41) CYP3A4ALDH1A1CA1CA2CA9
SCHEMBL9772291 0.79 TSHR (0.46) CYP3A4TSHRALDH1A1MAPK1ALOX15
SCHEMBL6691030 0.79 TSHR (0.46) CYP3A4TSHRALDH1A1MAPK1ALOX15
SCHEMBL31053156 0.78 CYP3A4 (0.50) CYP3A4TSHRALDH1A1MAPK1ALOX15
SCHEMBL119351 0.78 CYP3A4 (0.50) CYP3A4TSHRALDH1A1MAPK1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7041852-B2 Perfluoroalkylanilines BAYER CHEMICALS AG (DE) 2006-05-09 US claimed
US-20040152898-A1 Perfluoroalkylanilines LANXESS DEUTSCHLAND GMBH (DE) 2004-08-05 US claimed
EP-1418171-A1 Perfluoroalkylanilins Bayer Chemicals AG (DE) 2004-05-12 EP claimed
EP-1418171-B1 Verfahren zur Herstellung von Perfluoroalkylanilins SALTIGO GMBH (DE) 2011-12-14 EP disclosed
US-7041852-B2 Perfluoroalkylanilines BAYER CHEMICALS AG (DE) 2006-05-09 US disclosed
US-20040152898-A1 Perfluoroalkylanilines LANXESS DEUTSCHLAND GMBH (DE) 2004-08-05 US disclosed
EP-1418171-A1 Perfluoroalkylanilins Bayer Chemicals AG (DE) 2004-05-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152898-A1 Perfluoroalkylanilines PFAS, AFF2, AFF4 CYP3A4 97/4885TSHR 601/4885ALDH1A1 1098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.